Big Pharma targets higher global drug prices, challenging foreign budgets and Trump's US cost-cutting.

The article discusses Trump's efforts to negotiate drug prices with pharmaceutical companies, focusing on the 'most favored nation' policy that aims to align U.S. drug prices with those in other wealthy countries, while highlighting the challenges of convincing foreign governments to increase their spending on pharmaceuticals.